Parkinson's research gets a $4 million funding boost
The APDA committed $4.04M for 2025–2026 — a 55% increase — spanning new therapies, brain-circuit science, and research equity.
The American Parkinson Disease Association has announced $4.04 million in new research funding for the 2025–2026 grant cycle — a 55% increase over the previous year. The grants span basic science, novel therapies, and work aimed at improving day-to-day quality of life.
This cycle introduced new categories, including Social Science Research Grants that focus on the psychological and social dimensions of living with Parkinson's. Funding also continues to back early-career scientists and, through the Diversity in Parkinson's Disease Research Grant, researchers and communities that have historically been underrepresented.
Across the portfolio, priorities include alpha-synuclein pathology, freezing of gait, cognitive impairment, brain-circuit mechanisms, and health disparities — reflecting a push to understand the disease earlier and treat it more effectively.
This is an in-house summary. Read the full reporting at the original source:
